MedTrace Logo

Clinical Evaluation of Dimethyl Sulfoxide Dentin Pre-treatment

NCT04492306 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2023-02-09

No results posted yet for this study

Summary

This study is conducted in order to evaluate the clinical effectiveness of 1% DMSO dentin pre-treatment on the clinical performance of etch and rinse adhesive.

Conditions

  • Dental Diseases

Interventions

OTHER

Dimethyl Sulfoxide

DMSO \[(CH3)2SO\] is a polar aprotic solvent that dissolves both polar and non-polar compounds.

OTHER

3M ESPE Single bond 2

Total etch adhesive bond

OTHER

Filtek Z350 XT, 3 M ESPE, St Paul, MN, USA)

Composite Resin

OTHER

3m ESPE etch

32% phosphoric acid

Sponsors & Collaborators

  • University of Turku

    collaborator OTHER

  • Cairo University

    lead OTHER

Principal Investigators

  • Randa Hafez, Professor · Cairo U

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-17
Primary Completion
2022-12-30
Completion
2022-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04492306 on ClinicalTrials.gov